Brian K. Halak, 10% Owner at Esperion Therapeutics, Inc. (ESPR), bought 316,176 shares at $14.00 ($4.0M) on 2013-07-01, disclosed to the SEC on 2013-07-02.
Open-market purchase of $4.0M ESPR by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 30,462 | $0 | 0.0% |
| 2 | $14.00 | 4,791 | $67K | 1.7% |
| 3 | $14.00 | 280,923 | $3.9M | 98.3% |
| Total | $12.65 avg | 316,176 | $4.0M | 100% |
| Filing → |
| DRNA | SELL | 2018-11-01 | $2.5M | — | Filing → |
| EVOK | SELL | 2015-08-20 | $1K | — | Filing → |
| ATRA | BUY | 2014-10-21 | $20K | — | Filing → |